Depo-Provera Lawsuit
Important Information Regarding Depo-Provera Meningioma Lawsuits
A recent study conducted by researchers at the National Agency for Medicines and Health Products Safety in France, and published in the March, 2024 issue of the British Medical Journal (BMJ), indicates women who used Depo-Provera for more than a year had a 5-fold increased risk of developing a meningioma (brain tumor) than women who did not use the drug.
The researchers discovered a correlation between the prolonged use of a progestogen-based drug, with an increased risk of developing meningiomas.
The study found that medroxyprogesterone acetate, a progestogen-based contraceptive drug, sold under the brand name Depo-Provera®, increased the risk of meningioma by 5X, with long-term use.
If you or a loved-one developed a brain tumor/meningioma after taking Depo-Provera, call me and I’ll Make Them Pay!®
Who Can File a Depo-Provera Lawsuit?
You must meet the following criteria to be eligible to file a Depo-Provera lawsuit:
1. You used Pfizer’s brand-name Depo-Provera at least twice,
OR
2. You used Pfizer’s brand-name Depo-SubQ Provera at least twice,
OR
3. You used an “authorized generic” version of Depo-Provera at least twice, manufactured by one of the following;
- Pharmacia & Upjohn Company LLC
- Greenstone LLC
- A-S Medication Solution
- Prasco Laboratories
- Preferred Pharmaceuticals Inc.
AND
4. You were diagnosed with meningioma after using Depo-Provera or Depo-SubQ Provera based on the criteria stated above
Pfizer’s Response to Depo-Provera Meningioma Lawsuits
In response to the published research report, Pfizer, the manufacturer of Depo-Provera, acknowledged the potential risks associated with long-term progestogen use. According to The Guardian, Pfizer plans to update product labels and patient information leaflets, to better inform users and their prescribers.
As a result of these serious findings, numerous lawsuits against Pfizer have been initiated. The lawsuits allege Pfizer failed to adequately warn users and healthcare providers of the potential risks using Depo-Provera. Some lawsuits allege Pfizer failed to conduct adequate testing prior to releasing Depo-Provera to the public.
About Depo-Provera
Depo-Provera, or Depot medroxyprogesterone acetate (DMPA), is a hormonal contraceptive injection. It is a commonly used form of birth control that is administered as an injection every three months.
The active ingredient, medroxyprogesterone acetate (MPA), was developed in the 1950s as a treatment for uterine cancer. In 1972, the U.S. Food and Drug Administration (FDA) denied approval of Depo-Provera as a contraceptive due to safety concerns.
Some 20 years later, in 1992, Depo-Provera was authorized for contraceptive use in the U.S. Currently, it is used for birth control and for the treatment of endometriosis, abnormal uterine bleeding, and certain cancers.
Depo-Provera has also been available as a generic medication for 20 years..
What Is a Meningioma?
A meningioma is a tumor that develops in the meninges of the brain. Meninges are membranes in the central nervous system (CNS), that surround the brain and spinal cord. The tumor can exude pressure on brain tissue, nerves and blood vessels. Meningiomas are the most common type of tumor found in the head.
Meningiomas can grow slowly, sometimes over years without causing symptoms. However, when tumors affect structures in the brain, they can result in significant disabilities.
As a drug injury lawyer for more than 40 years, I know what it takes to win an injury claim. Let me focus on winning your case while you focus on your health & well-being.
Don’t wait to contact me. If you were diagnosed with a meningioma after taking Depo-Provera, call me now to discuss your Depo-Provera injury claim. You may be entitled to significant compensation.